The Use of Apraclonidine in the Diagnosis of Horner Syndrome in Pediatric Patients

Archives of Ophthalmology

Volumn 122, Issue 2, 2004, Pages 276-279

  Bacal, Darron A ^b   Levy, Susan R ^a  

^a Eye Physicians and Surgeons ^*

^b Eye Physicians and Surgeons   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

APRACLONIDINE;

ADOLESCENT; ANISOCORIA; ARTICLE; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; DIAGNOSTIC TEST; DRUG MECHANISM; EYE MOVEMENT; HORNER SYNDROME; HUMAN; INFANT; MALE; MYDRIASIS; NEUROLOGIC EXAMINATION; PHYSICAL EXAMINATION; PRIORITY JOURNAL;

ADOLESCENT; ADRENERGIC ALPHA-AGONISTS; ANISOCORIA; CHILD; CLONIDINE; FEMALE; HORNER SYNDROME; HUMANS; INFANT; MALE; OPHTHALMIC SOLUTIONS; PUPIL;

EID: 0842283899     PISSN: 00039950     EISSN: None     Source Type: Journal    
DOI: 10.1001/archopht.122.2.276     Document Type: Article

References (6)

1. Kisch B. Horner syndrome, an American discovery. Bull Hist Med. 1951;25:284-288.
2. Jeffrey AR, Ellis FJ, Repka MX, Buncic JR. Pediatric Horner syndrome. J AAPOS. 1998;2:159-167.
3. Pilley SFJ, Thompson HS. Pupillary "dilation lag" in Horner syndrome. Br J Ophthalmol. 1975;59:731-735.
4. Morales J, Brown SM, Abdul-Rahim AS, Crosson CE. Ocular effects of apraclonidine in Horner syndrome. Arch Ophthalmol. 2000;118:951-954.
5. Thompson HS, Mensher JH. Adrenergic mydriasis in Horner's syndrome: hydroxyamphetamine test for diagnosis of postganglionic defects. Am J Ophthalmol. 1971;72:472-480.
6. Enyedi LB, Freedman SF. Safety and efficacy of brimonidine in children with glaucoma. J AAPOS. 2001;5:281-284.